Detailed Narrative
Q2 & H1 FY26 Financial Performance
Jupiter Life Line Hospitals reported a robust financial performance for Q2 and H1 FY26. The total operating income for Q2 stood at ₹374.4 crores, marking an 11.7% year-on-year increase, with EBITDA at ₹85.4 crores, growing 9.3% YoY and maintaining a 22.8% margin. For the first half of FY26, operating income reached ₹727.4 crores, up 14.9% YoY, and EBITDA was ₹163.8 crores, a 13.7% YoY increase, with a 22.5% margin. PAT for H1 FY26 grew 5.3% YoY to ₹101.4 crores.
Expansion Plans and Project Timelines
The company's expansion strategy is well on track. The Dombivali Hospital is nearing completion and is forecasted to commence operations in Q1 of the next financial year (FY27) without anticipated delays. Construction for the South Pune Hospital has begun in Q3 FY26, and the Mira Road Hospital is currently in the architectural drawing board phase. The company has spent approximately ₹110 crores on CAPEX for new projects in H1 FY26.
Occupancy and ARPOB Trends
For H1 FY26, the ARPOB stood at ₹66,100, and the average occupancy rate was 62.2% on expanded bed capacity. Q2 FY26 consolidated occupancy was 64.5%. Management noted that Thane hospitals are in the mid-70s occupancy, Pune is moving towards 70%, and Indore is showing increased occupancy and revenue. The Q2 occupancy in Pune was slightly lower than usual due to a reduced infection outbreak, which is a positive sign for community health.
Accounting Changes and One-time Items
Jupiter Life Line Hospitals has adopted a new accounting treatment for unbilled revenue, recognizing ₹19.2 crores in Q2 FY26. This change also led to a one-time📎 provision of ₹12 crores in professional fees, comprising ₹3 crores for the unbilled revenue and ₹9.3 crores for unsettled/outstanding bills. Management expects this to be a one-time📎 delta, with future quarters seeing these entries broadly cancel out.
Financial Strength and Debt Position
The company maintains a strong financial position with a consolidated debt of ₹325 crores, significantly offset by liquid investments and deposits exceeding ₹500 crores (around ₹550 crores as of September end). The blended cost of interest on the debt is between 7% and 8%, but the effective carrying cost is approximately 1% due to the substantial liquid assets. The company anticipates funding its ongoing three projects (Dombivali, South Pune, Mira Road) primarily through internal resources and future accruals.
Strategic Outlook and Payer Mix
The company's focus remains on expanding its presence in Western India by building high-quality hospital infrastructure. The payer mix for H1 FY26 remained stable, with insurance accounting for 55.5% of revenue, self-payers 43.2%, and government schemes 1.3%. Management is open to inorganic growth opportunities in Western India, including Gujarat and Madhya Pradesh, but currently has no live discussions.